Adagrasib can cause serious side effects like gastrointestinal issues, liver problems, and cardiac concerns. Patients should be monitored closely during treatment.

Warnings and Precautions

Gastrointestinal issues: Including nausea, diarrhea, and vomiting. Severe cases may require dose adjustments or discontinuation.

Cardiac issues: QTc prolongation is possible, increasing the risk of serious arrhythmias. Monitoring of heart activity is recommended.

Liver toxicity: Liver function tests should be performed before and during treatment.

Lung issues: Adagrasib may cause pulmonary inflammation leading to fatal outcomes.

Adagrasib(Krazati)
Adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) or colorectal cancer (CRC).
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved